The American pharmaceutical giant Pfizer Inc. requested Friday’s formal approval of the COVID-19 vaccine by Japan, making it the country’s first supplier to do so.
The Japanese government has already agreed with Pfizer to receive a supply of 120 million doses of vaccine, enough for 60 million people, or about half of its population.
The United States and Britain have already begun administering the coronavirus vaccine jointly developed by Pfizer and its German partner BioNTech SE, while Singapore and some other countries are expected to do the same.
But there are still concerns about his safety after U.S. local authorities said Wednesday that an Alaska health worker had shown a severe allergic reaction to the vaccine. In Britain, similar allergic reactions have also been reported in two health workers.
Earlier this month, the diet enacted a law to cover residents ’vaccination costs, amid a resurgence of infections that shows no signs of declining.
As vaccinations could begin as early as March, the government plans to ask municipalities to prepare sites in addition to medical institutions before the launch, as well as establish systems to accept reservations.
The Pfizer-BioNTech vaccine is expected to be delivered in batches of 1,000 doses, but should be stored at less than 75 degrees Celsius or less and administered in approximately 10 days.
In a time of misinformation and too much information, quality journalism is more crucial than ever.
If you subscribe, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
